Fischer A - Search Results

1

Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.

Zhou Z, Fan Y, Thomason D, Tang W, Liu X, Zhou ZY, Macaulay D, Fischer A. Zhou Z, et al. Among authors: fischer a. Adv Ther. 2019 May;36(5):1100-1113. doi: 10.1007/s12325-019-00929-2. Epub 2019 Mar 30. Adv Ther. 2019. PMID: 30929184 Free PMC article.

2

Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States.

Zhou Z, Fan Y, Tang W, Liu X, Thomason D, Zhou ZY, Macaulay D, Fischer A. Zhou Z, et al. Among authors: fischer a. J Rheumatol. 2019 Aug;46(8):920-927. doi: 10.3899/jrheum.180445. Epub 2019 Feb 15. J Rheumatol. 2019. PMID: 30770505 Free article.

3

Humanistic and cost burden of systemic sclerosis: A review of the literature.

Fischer A, Zimovetz E, Ling C, Esser D, Schoof N. Fischer A, et al. Autoimmun Rev. 2017 Nov;16(11):1147-1154. doi: 10.1016/j.autrev.2017.09.010. Epub 2017 Sep 9. Autoimmun Rev. 2017. PMID: 28899803 Free article. Review.

4

Interstitial lung disease in connective tissue disorders.

Fischer A, du Bois R. Fischer A, et al. Lancet. 2012 Aug 18;380(9842):689-98. doi: 10.1016/S0140-6736(12)61079-4. Lancet. 2012. PMID: 22901890 Review.

5

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. Among authors: fischer a. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.

6

Interstitial lung disease in undifferentiated forms of connective tissue disease.

Fischer A, Brown KK. Fischer A, et al. Arthritis Care Res (Hoboken). 2015 Jan;67(1):4-11. doi: 10.1002/acr.22394. Arthritis Care Res (Hoboken). 2015. PMID: 25048539 Free article. Review. No abstract available.

7

All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.

Fischer A, Kong AM, Swigris JJ, Cole AL, Raimundo K. Fischer A, et al. J Rheumatol. 2018 Feb;45(2):235-241. doi: 10.3899/jrheum.170307. Epub 2017 Nov 15. J Rheumatol. 2018. PMID: 29142033

8

Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.

Solomon JJ, Fischer A. Solomon JJ, et al. Among authors: fischer a. J Intensive Care Med. 2015 Oct;30(7):392-400. doi: 10.1177/0885066613516579. Epub 2013 Dec 25. J Intensive Care Med. 2015. PMID: 24371251 Review.

9

Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease.

Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Fischer A, et al. Chest. 2006 Oct;130(4):976-81. doi: 10.1378/chest.130.4.976. Chest. 2006. PMID: 17035427

10

Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality.

Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris JJ. Raimundo K, et al. Among authors: fischer a. J Rheumatol. 2019 Apr;46(4):360-369. doi: 10.3899/jrheum.171315. Epub 2018 Nov 15. J Rheumatol. 2019. PMID: 30442831 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,250 results

Search Page

Filters